willdate

2217 POSTS 0 COMMENTS

Scott Drake appointed as Cordis CEO

Cordis has announced ...

Recor Medical gains first US FDA renal denervation approval

Recor Medical has bec...

EACTS 2023: Statin treatment may benefit SAVR patients

Ongoing statin treatm...

US FDA approval for AI-powered left ejection fraction detection device

AI
Anumana has announced US ...

MedAlliance acquired by Cordis

MedAlliance has been acqu...

Nitrate reduces contrast-induced necropathy during coronary angiography

Inorganic nitrate reduces...

Nick West appointed to associate CMO role at Shockwave Medical

Shockwave Medical has...

David Hildick-Smith

As one of the UK’s leader...

Cardiovascular News – Issue 70 – September 2023: US Edition

In this issue: Socie...

Cardiovascular News – Issue 70 – September 2023: OUS Edition

In this issue: Socie...

Pivotal study of ShortCut leaflet splitting device completes enrolment

Pi-Cardia has announced t...

Updates to HyperVue intravascular imaging system approved by US FDA

SpectraWAVE has announced...

Enrolment complete in SAFE-MCS study of Early Bird bleed monitoring system

Saranas has completed enr...

Half of patients enrolled in SELUTION DeNovo coronary trial

MedAlliance has announced...

Stroke expert J Mocco joins Protembis board

Protembis has announced t...

Elevate pLVAD completes early feasibility study

Enrolment has been comple...

Bryan Williams joins BHF as research leader

The British Heart Fou...

AI model may improve detection of atrial septal defect

An artificial intelligenc...

Efforts needed to improve cardiovascular research in Africa

Research published in...

STAR-T trial of DrugSorb-ATR completed

CytoSorbents has announce...

CMS creates new MS-DRG codes and payments for coronary IVL

Shockwave Medical has ann...

WHO adds cardiovascular polypill to essential medicines list

The World Health Organiza...

CardioPrecision moves into US market

CardioPrecision, a develo...

EACTS puts innovation to the fore

Innovation is a part ...

Michael Jaff joins board of directors at HeartBeam

HeartBeam, developer ...

PECA Labs appoints new board members

PECA Labs has added Jeffr...

Timeline: Key milestones in the paclitaxel story

The release of a letter f...

Approval granted to commence study of renal pelvis denervation system

Verve Medical has receive...

First patient enrolled in MOJAVE study of DSR 2.0

Sequana Medical NV has an...

Key messages from EBC MAIN at three years

EBC MAIN investigator...

Depressed ICD patients “more likely to stop medications”

heart attack
Patients who feel low...

iTFlow blood flow analysis software gains US FDA approval

The US Food and Drug Admi...

CorWave closes series C funding round

CorWave has raised €61 mi...

ESC appoints Jean-François Riffaud as CEO

The European Society ...

Translumina extends European reach with Lamed acquisition

Translumina has annou...

Lars Søndergaard joins Abbott’s structural heart business

Lars Søndergaard has left...

Conformal Medical completes series D financing round

Conformal Medical has...

ADVERTORIAL: Keeping stroke at bay for patients undergoing TAVI

This advertorial is spons...

Ruggero De Paulis

Inventor of the Valsalva ...

Cardiovascular News – Issue 69 – May 2023: OUS Edition

In this issue: A new...

EuroPCR 2023: Robocath launches new robotic PCI platform

Robocath has announced th...

Foldax acquires proprietary polymer patent family

Tria
Foldax has announced ...

SavvyWire to be assessed in COMPLETE TAVR substudy

OpSens has announced the ...

Turning extra pulses into pluses

This educational suppleme...

More shocks for rocks

How has the new Shock...

Managing eccentric and nodular calcium with IVL

Calcified nodules are...

The r(evolution) of calcium in Bristol

Tom Johnson (Universi...

US FDA expands indication for Farxiga

AstraZeneca’s Farxiga (da...

Carillon mitral contour system gains EU MDR certification

Cardiac Dimensions ha...

CAAS Qardia gains Japanese certification

Pie Medical Imaging has r...

OpSens completes European enrolment in SAFE-TAVI study

OpSens has announced the ...

Cardiovascular News’ top 10 stories of March 2023

The news agenda in March ...

PROACTIVE-HF pivotal trial completes enrolment

Endotronix has announ...

Smart glasses guide remote support for pioneering TAVI procedure

The UK’s first remotely-s...

Enrolment target met in ECLIPSE coronary atherectomy trial

Cardiovascular System...

Experts update consensus on left atrial appendage closure

The Society for Cardi...

Azeem Latib joins Supira Medical as medical director

Supira Medical has an...

Thousandth patient enrolled in SELUTION DeNovo coronary study

MedAlliance has announced...

US FDA approval for Essenz heart-lung machine

LivaNova has announced th...

Preclinical model could aid future research of NSTEMI therapies

Researchers have detailed...

HyperVue intracoronary imaging system gains US FDA approval

SpectraWAVE has announced...

Medtronic relaunches Harmony transcatheter pulmonary valve

Medtronic has announced t...

Barostim misses primary endpoint in BEAT-HF postmarket trial

CVRx has announced the pr...

US FDA clears tool to rapidly analyse RV/LV ratio

RapidAI announced it has ...

Renal denervation “can reach new shores”

The publication of a ...

Teleflex grows catheter portfolio following US FDA approval

Teleflex Incorporated has...

Xeltis secures funding to progress clinical trials

Xeltis has raised €32 mil...

ACC, AHA and SCAI lay roadmap for interventional cardiology training

The American College of C...

OPN NC “super-high-pressure” coronary balloon launches in USA

SIS Medical AG has announ...

GE HealthCare to acquire AI ultrasound developer Caption Health

GE HealthCare has sig...

Cardiovascular News 68 – February 2023: US Edition

In this issue: Medic...

Cardiovascular News 68 – February 2023: OUS Edition

In this issue: Medic...

TruLeaf Medical to trial “two-stage” TMVR platform

TruLeaf Medical is to...

Cardiovascular-aortic community comes together at CX 2023

From cutting-edge aortic ...

Nieves Gonzalo

Interventional cardiology...

Shockwave agrees to acquire Neovasc

Shockwave Medical has...

HVR Cardio closes €10.7 million series B funding round

HVR Cardio has closed...

Funding secured to advance development of Pulse IVL system

AVS has announced that it...

Cardiovascular News’ top stories of 2022

Which stories, features a...

SCAI announces recipients of early career grant scheme

The Society for Cardiovas...

Johnson & Johnson completes Abiomed acquisition

Johnson & Johnson has...

Corindus rebrands to Siemens Healthineers Endovascular Robotics

Corindus has been reb...

EU Commission to propose delay to MDR implementation

Europe’s health commi...

First-in-human procedure performed using Impella RP Flex

The first implant procedu...

Late-breaking Xlimit randomised trial data shared at CSC 2022 congress

Data presented at an inno...

Timothy D Henry

A pioneer of one of the f...

Carmat resumes commercial implants of Aeson artificial heart

Carmat has announced the ...

AI system to aid decision making for aortic aneurysm treatment

viz series d
Viz.ai has announced a pa...

US FDA accepts post-approval study reports for Impella

Abiomed has announced...

First patients treated in SAFE-TAVI clinical study

OpSens Medical has announ...

MedAlliance to be acquired by Cordis

MedAlliance is to be acqu...

Rates of stroke and embolism lower with apixaban compared to rivaroxaban

In a large, population-ba...

Abiomed gains FDA approval for Impella low profile sheath

The US Food and Drug ...

EACTS 2022: “Wake up call” for trialists over gender balance

Clinical trials in ca...

Latest data underscore optimism for future of renal denervation

Ajay Kirtane (Columbi...

Long-term P2Y12 monotherapy after PCI “may be a promising strategy”

Three-year outcomes from ...

Enrolment completed in trial comparing PCI in diabetic patients

ABILITY DIABETES-GLOBAL, ...

Data from BIOSOLVE-IV and BIOMAG-I trials shared at TCT 2022

Biotronik has announc...

FDA approves Onyx Frontier and Resolute Onyx stents for bifurcation PCI

Medtronic has received Fo...

Shockwave initiates all female coronary IVL registry study

Shockwave Medical has ini...

TCT 2022: Amulet occluder keeps pace with Watchman at three years

Long-term follow-up o...

TCT 2022 hears “important data” from renal denervation trials

Findings from the RAD...

Abiomed given green light for RECOVER IV randomised trial

Abiomed has announced two...

First patient joins study of SSO2 therapy post-PCI

Zoll Medical has announce...

Abbott’s Amplatzer Talisman PFO occlusion system launched in Europe

Abbott has announced the ...

Tom Nguyen

As a proponent of minimal...

Cardiovascular News’ top 10 most popular stories of August 2022

The most read stories fro...

FDA clears Viz.ai’s right-to-left ventricle ratio algorithm

Viz.ai has received US Fo...

Programme released for TCT MedTech Innovation Forum

The Cardiovascular Re...

Cardiovascular News 66 – August 2022: OUS Edition

In this issue: Call ...

Cardiovascular News 66 – August 2022: US Edition

In this issue: Call ...

Spotlight turns to TAVI in patients with moderate aortic stenosis

Ongoing clinical tria...

Cardiovascular News’ top 10 most popular stories of July 2022

The most read stories fro...

Three-year results of RANGO registry presented at EuroPCR

iVascular has announced t...

HeartBeam expands software platform to cover unstable angina

HeartBeam is expanding th...

First patient treated in HEAL-IST clinical trial

AtriCure has announced th...

SCAI names Sunil Rao as incoming president

Sunil Rao (Duke Unive...

Cardiovascular News 65 – May 2022: US Edition

In this issue: New d...

Cardiovascular News 65 – May 2022: OUS Edition

In this issue: New d...

Vijay Kunadian

Vijay Kunadian (Newcastle...

ADVERTORIAL: TAVI valve durability under the microscope

This advertorial is s...

Cardiovascular News’ top 10 most popular stories of April 2022

The most read stories fro...

DCB in PCI: Adjunctive therapy or standard of care?

This educational suppleme...

“TAVI was my baby, now it is a teenager”

In the history of transca...

Health Canada approval granted for SavvyWire TAVI guidewire

OpSens has announced that...

First patient enrolled in EXPAND TAVR II trial

Medtronic has announc...

SCAI issues position paper on transaxillary arterial access

The Society for Cardiovas...

FDA approves coronary use of XO Cross support catheter system

Transit Scientific ha...

Quest International and CathWorks partner to scale up FFRangio

Quest International a...

VenusP-Valve gains CE mark

VenusP-Valve
Venus Medtech's trans...

CeloNova to seek medical device partnerships

CeloNova BioSciences ...

SafeCross transseptal balloon gets first commercial use

East End Medical has ...

Philips launches Ultrasound Workspace at ACC.22

Royal Philips is launchin...

Shockwave coronary IVL gains Japanese approval

Shockwave Medical’s C2 co...

First patient enrolled in PICSO-AMI-V study

Miracor Medical has a...

RADIANCE-II renal denervation trial completes enrolment

Investigators have comple...

Deep learning tool could predict future myocardial infarction

Researchers have deta...

Venus Medtech targets European growth with senior appointment

Venus Medtech has appoint...

Women less likely to receive cardiogenic shock treatment

Woman patient
Women are less likely to ...

Putting “stent regret” behind us

Nick West, chief medi...

CSI’s Propel pVAD system gets first-in-human use

Cardiovascular Systems—CS...

Cardiologists without borders

“When I was one year ...

Ryan Egeland joins Big Sky Biomedical

Big Sky Biomedical ha...

Partnership to promote wearable tech in cardiology trials

Wearable technology and d...

New data underpin drive towards earlier AF ablation strategies

Historically, cathete...

Valve-in-valve TAVI outperforms repeat SAVR for in-hospital mortality

Valve-in-valve transc...

Robert Califf to return as US FDA commissioner

Cardiologist and rese...

Expanded robotic training will benefit cardiovascular care

Robotic systems have the ...

3D printing to support physician training and coronary device testing

The donation of new 3...

Enrolment completed in BIOADAPTOR trial of Dynamx coronary implant

Elixir Medical has an...

Boston Scientific closes acquisition of Baylis Medical Company

Boston Scientific has...

MedHub announces investment and pivotal study completion

MedHub has announced the ...

Second phase of ASCENT ASD trial begins

Atheart Medical has a...

Susheel Kodali

Born in India and rai...

Cardiovascular News 64 – February 2022: US Edition

In this issue:  Coro...

PROACT clinical trial results published for On-X mechanical mitral valve

Artivion has announced th...

SCAI issues updated expert consensus statement on cardiogenic shock

The Society for Cardi...

InnovHeart completes funding round to advance Saturn TMVR system

InnovHeart, developer of ...

JIM 2022 moves to June slot

Organisers of the Joint I...

Grant funding for 3D-printed paediatric heart models

Congenita has been named ...

Gore’s Cardioform Septal Occluder reaches 10-year milestone

WL Gore & Associa...

Young surgeons to benefit from Transatlantic grant scheme

In a joint programme ...

Omicron surge sees STS move 2022 annual meeting online

The Society of Thoracic S...

Robocath completes European study of robot-assisted PCI

Robocath has announced th...

Impella gains a trio of regulatory approvals

Regulators in three count...

Evolut PRO TAVI valve gains approval in China

Medtronic has announc...

Cardiovascular News’ top 10 most popular stories of December 2021

cardiovascular news top 10
The most read stories fro...

First patient enrolled in COSIRA-II trial of Neovasc Reducer

Neovasc has announced enr...

FDA clears CavaClear IVC filter removal laser sheath

Royal Philips has ann...

First clinical results for Tria biopolymer valve published

Tria
Foldax has announced ...

Initial implants of Thubrikar TAVI system to commence

Thubrikar Aortic Valve ha...

AI improves confidence in CAD detection from a stress echocardiogram

Ultromics has announc...

HeartFlow submits premarket application for coronary plaque assessment

HeartFlow has announced i...

Opsens files 510(k) submission to US FDA for TAVI guidewire

Opsens has filed a 510(k)...

Understanding the risk of acute kidney injury in the cath lab

Huge strides have bee...

Philips expands cardiac ultrasound portfolio

Royal Philips has ann...

Foldax commences clinical study of Tria surgical aortic valve in India

Tria
Foldax has announced that...

Venus Medtech announces Cardiovalve acquisition

Venus Medtech has announc...

SyMap Medical closes US$100 million financing round

SyMap Medical has ann...

Survey: Bullying “commonly experienced” by UK cardiology trainees

One in 10 junior doctors ...

Interim REVERSE-IT trial results published in NEJM Evidence

Interim results from ...

Cardiovascular News’ top 10 most popular stories of November 2021

cardiovascular news top 10
Featuring stories from th...

AI-based algorithm could predict outcomes after cardiac surgery

AI
A novel artificial intell...

Mirvat Alasnag

Mirvat Alasnag is the Gul...

CSI recalls Wirion embolic protection device

Cardiovascular Systems ha...

First patients enrolled in FAST III study of vFFR-guided PCI

The first patients have b...

What to expect from AHA 2021

Ahead of the American Hea...

Lessons from SURTAVI

Transcatheter aortic valv...

Cardiovascular News 63 – November 2021: US Edition

In this issue:  MAST...

Cardiovascular News 63 – November 2021: OUS Edition

In this issue:  MAST...

Aktiia announces Series A funding round

Hypertension health-t...

TCT 2021: Studies to highlight patient outcomes with Impella

Results from two studies ...

Bifurcation lesions: Exploring the latest science

This educational suppleme...

CRF waives cost for digital access to TCT 2021

The Cardiovascular Resear...

Cardiac CTA parameters predict post-TAVI mortality

Cardiac CT angiograph...

First European implants of Trilogy TAVI system completed

JenaValve Technology has ...

Heartflow announces start of REVEALPLAQUE clinical trial

HeartFlow has announced t...

Enrolment completed in study of Tria aortic valve

Tria
Foldax has announced comp...

Siemens launches Luminos Impulse fluoroscopy system

Siemens Healthineers has ...

Abbott’s Amplatzer Talisman gains FDA approval

Abbott has announced that...

Biotronik gains FDA approval for the Orsiro Mission drug-eluting stent

Orsiro Mission DES
Biotronik has announc...

Open Stent Solution closes €2.5 funding round

Open Stent Solution (OSS)...

HRX digital health event moved to September 2022

The Heart Rhythm Society ...

Cardiac, vascular and endovascular leaders convene for CX Aortic Vienna

CX Aortic Vienna
Capturing the latest deve...

ADVERTORIAL: Optimising TAVI device choice

This advertorial is spons...

Neovasc to begin COSIRA-II trial of Reducer for refractory angina

Neovasc has announced tha...

Randomised trials needed to evaluate safety and efficacy of TMVR

Randomised trials are...

Abbott receives FDA approval for Portico with FlexNav TAVI system

Abbott has announced ...

TCT 2021: Late-breaking trials programme announced

The Cardiovascular Re...

Christoph Naber

Christoph Naber (Essen, G...

ABILITY Diabetes Global enrols thousandth patient

Concept Medical has annou...

Digital app speeds up time to STEMI care

“During a heart attac...

Cardiovascular News’ top 10 most popular stories of August 2021

cardiovascular news top 10
August’s top 10 features ...

HeartFlow announces enrolment of first three patients in FUSION trial

HeartFlow has announc...

Second hospital implants Aeson bioprosthetic artificial heart

CARMAT has announced the ...

EMPOWER trial to study Carillon mitral contour system

Cardiac Dimensions ha...

Cardiovascular News 62 – August 2021: OUS Edition

In this issue: Meta ...

Cardiovascular News 62 – August 2021: US Edition

In this issue: Meta ...

Ten-year outcomes of Yukon DES in diabetic patients published in JAHA

Translumina has announced...

Ultromics completes US$33 million Series B funding round

Ultromics, a developer of...

FDA grants breakthrough device designation to Impella ECP

The US Food and Drug ...

Algorithm predicts heart failure hospitalisations

AI
Biotronik has announced t...

Abbott’s Amplatzer Amulet gains US FDA approval

Abbott has announced ...

Occlutech gains IDE approval for OCCLUFLEX pivotal study

Occlutech Holding has ann...

Realview Imaging gains FDA approval for Holoscope-i system

RealView Imaging has anno...

Back in the room: A welcome return to in-person education

With the COVID-19 pan...

US launch for Abbott’s Ultreon AI-based coronary imaging platform

Abbott has announced that...

PCI procedures drop by 10% in USA since 2010, research suggests

The USA saw a 10% dec...

AngelMed launches its Guardian device in the USA

Angel Medical Systems (An...

MedAlliance launches Origin balloons for vessel preparation

MedAlliance has launched ...

Ancora Heart secures US$80 million in financing

Ancora Heart has clos...

HeartFlow announces merger agreement

HeartFlow has entered...

First Aeson bioprosthetic artificial heart implanted in USA

Carmat has announced the ...

FDA approval for SafeCross transseptal RF system

East End Medical has ...

Cardiovascular societies demand action to combat physician burnout

Global action is needed t...

Electroducer raises funding to market its external pacemaker device

Electroducer has announce...

Vaccine myocarditis risk “far outweighed” by COVID-19 infection

The risk of heart damage ...

Tendyne receives breakthrough designation for MAC patients

Abbott has received B...

Royal Philips announces start of DEFINE GPS study

Philips iFR Coregistration SyncVision
Royal Philips has ann...

Cindy Grines

Cindy Grines is an interv...

“Rapid increase” in cardiovascular disease-related deaths in Asia

The number of people dyin...

Study of CorWave’s LVAD presented at ASAIO annual meeting

CorWave has announced tha...

Delaying CABG after AMI may not improve outcomes

A study looking at the ti...

Medtronic stops sale of its HVAD system

Medtronic is stopping...

Cardiovascular News’ top 10 most popular stories of May 2021

cardiovascular news top 10
Our top 10 stories of May...

Physician gender does not impact outcomes in PCI patients

There does not appear to ...

Abiomed acquires breakthrough device company preCARDIA

Abiomed has acquired preC...

MDR comes into effect across EU

The European Union (EU) M...

First-in-human use of Tria biopolymer heart valve completed

Tria
Foldax has announced the ...

First patients treated with Aortix pMCS device

complete-revascularisation
Procyrion has announced t...

ZOLL Medical receives FDA IDE approval for ISO Shock study

ZOLL Medical Corporat...

Abbott’s Navitor TAVI system receives CE mark

Abbott has announced it h...

Leaflex: Changing the conversation around aortic stenosis?

This advertorial is spons...

Cardiovascular News 61 – May 2021: OUS Edition

In this issue: Hosti...

Cardiovascular News 61 – May 2021: US Edition

In this issue: ...

Mild COVID-19 unlikely to lead to lasting heart damage

Mild COVID-19 infection i...

Cardiovascular News’ top 10 most popular stories of April 2021

cardiovascular news top 10
Our top 10 stories of Apr...

ACC.21: App speeds up time to PCI for STEMI patients

ST-elevation myocardial i...

CE mark for BACE device for functional mitral regurgitation

Phoenix Cardiac Devices h...

CytoSorbents granted US FDA approval for STAR-T trial

CytoSorbents has announce...

Researchers create heart replicas from CT images

Researchers from King's C...

Cardiothoracic surgeons mobilised for COVID-19 research

The work of the Cardiotho...

AcQCross transseptal crossing devices gain US FDA clearance

Acutus Medical has announ...

First procedure performed in SMART head-to-head TAVI study

The first procedure h...

Next generation TriClip gains CE mark approval

Abbott has received CE ma...

Understanding trends in TAVI and surgical aortic valve replacement

With recent data pointing...

Xience stent receives CE mark for short duration DAPT

Abbott has announced ...

Dipti Itchhaporia begins term as ACC president

Dipti Itchhaporia has...

Randomised trial data supports use of the PleuraFlow system

ClearFlow has announced c...

One in three female cardiologists report unwanted advances

More than a third of fema...

Alvimedica gains CE mark approval for Fluydo NC balloon catheter

Alvimedica has announced ...

Viagra may prolong life for men with coronary artery disease

Men with stable coron...

Shockwave Medical to bring IVL to the Chinese market

Shockwave Medical has ann...

Mavacamten granted US FDA new drug application

Bristol Myers Squibb has ...

Stephan Achenbach

Stephan Achenbach is prof...

Five-year results of Gore REDUCE clinical study published

Five-year follow-up r...

ACC.21 late-breaking clinical trial programme announced

The American College of C...

Cardiovascular News’ top 10 most popular stories of February 2021

cardiovascular news top 10
Our top 10 stories of Feb...

Approval allows use of single access Impella procedure across Europe

Following consultation wi...

ICS announces first use of its Emblok system in Europe

Innovative Cardiovasc...

FDA approval for Viola clampless proximal anastomosis device

Vascular Grafts Solutions...

ACC.21 switches to a virtual-only meeting

The American College of C...

OpSens gains CE mark for OptoWire III

OpSens has received CE ma...

Teleflex completes enrolment in CTO-PCI IDE study

Teleflex has announced th...

Global heart failure cases soar since 1990

The number of patients wi...

Robotic treatment starts with the heart

Robotic-assisted treatmen...

iVascular announces availability of Angiolite DES for longer lesions

iVascular has announced t...

COVID-19 patients at greater risk of death after cardiac arrest

COVID-19 patients who suf...

STS 2021: Sean C Grondin elected STS president

Cardiothoracic surgeon Se...

STS 2021: Study identifies significant gender disparities in CABG

Women are significantly l...

STS 2021: Cardiothoracic surgery suffers due to COVID-19

The COVID-19 pandemic...

STS 2021: Study of Impella 5.5 reports 79% survival rate at explant

A study of 356 patients t...

Analysis of ADAPT-DES registry grades risk of stent thrombosis after PCI

An analysis of data from ...

Cardiovascular News 60 – February 2021: OUS Edition

In this issue: Long-...

Cardiovascular News 60 – February 2021: US Edition

In this issue: Long-...

Study backs biopolymer used in Foldax’s Tria valve

Tria
Foldax has today anno...

Social determinants key in assessing coronary heart disease risk

A patient’s risk of c...

Patients “fearful” of seeking cardiac care during pandemic

Analysis of data from Eng...

Diamondback 360 atherectomy system gains CE mark

Cardiovascular System...

Elixir Medical announces treatment of first patient in BIOADAPTOR trial

Elixir Medical, a develop...

Abbott receives expanded Medicare reimbursement for MitraClip

Abbott has announced ...

ACC.21 to offer remote COVID-19 screening

The American College of C...

Ultromics receives FDA clearance for EchoGo Pro

The US Food and Drug ...

CorWave secures €35 million investment

CorWave has rasied €35 mi...

VDYNE secures funding for studies of tricuspid valve replacement device

VDYNE has announced today...

ADVERTORIAL: What does SCOPE II tell us about TAVI device trials?

This advertorial is spons...

Jian’an Wang named as editor of JACC: Asia

Jian’an Wang (Heart Cente...

CardioFlux imaging system granted Breakthough Device Designation

Genetesis has announced t...

ACC partners with Amgen and Veradigm on TRANSFORM: ACS study

The American College ...